Optimal timing of cholecystectomy in children with gallstone pancreatitis

Faidah Badru1, Saurabh Saxena1, Robert Breeden2

  • 1Department of Pediatric Surgery, Cardinal Glennon Children's Hospital, St. Louis, Missouri.

Insights

Pediatric gallstone pancreatitis recurrence is reduced with timely cholecystectomy. Performing surgery during the initial hospital stay for gallstone pancreatitis prevents pancreatitis recurrence and readmissions.

Area of Science:

  • Pediatric Gastroenterology
  • Surgical Outcomes
  • Biliary Tract Disease

Background:

  • Gallstone pancreatitis recurrence rates in pediatric patients awaiting cholecystectomy are not well-documented.
  • Acute gallstone pancreatitis requires prompt management to prevent complications.

Purpose of the Study:

  • To evaluate the recurrence rate of pancreatitis in pediatric patients after acute gallstone pancreatitis.
  • To determine the impact of cholecystectomy timing on pancreatitis recurrence.

Main Methods:

  • Retrospective chart review of pediatric patients (2007-2015) with gallstone pancreatitis.
  • Patients categorized into five groups based on cholecystectomy timing: during index admission, within 2 weeks, 2-6 weeks, >6 weeks post-discharge, and no surgery.
  • Pancreatitis recurrence rates were calculated for each group.

Main Results:

  • Of 48 patients, 19 underwent cholecystectomy during the index admission with zero recurrence.
  • Among patients not operated on during index admission (n=29), 31% experienced pancreatitis recurrence or readmission.
  • Recurrence rates varied by timing: 25% (2-week group), 37.5% (2-6 week group), 60% (>6 week group), and 12.5% (no surgery group).

Conclusions:

  • Cholecystectomy during the index admission for gallstone pancreatitis is associated with no recurrence or readmission.
  • Early cholecystectomy following gallstone pancreatitis resolution during the index admission is recommended for pediatric patients.
Abstract

Related Concept Videos

Chronic Pancreatitis II: Collaborative Care01:29

Chronic Pancreatitis II: Collaborative Care

The management of chronic pancreatitis is multifaceted, involving a comprehensive approach that includes thorough assessment, diagnostic testing, and a variety of management strategies.
Assessment:
433
Acute Pancreatitis II: Clinical Manifestations and Management01:30

Acute Pancreatitis II: Clinical Manifestations and Management

Acute pancreatitis presents a complex medical emergency characterized by rapid onset inflammation of the pancreas, demanding timely diagnosis and management to prevent complications. The condition primarily manifests through severe upper abdominal pain that often radiates to the back. This pain intensifies following the consumption of fatty foods. Accompanying symptoms such as nausea, vomiting, abdominal distention, fever, dyspnea, cyanosis, and jaundice can vary in intensity but significantly...
957
Endoscopic Procedures V: ERCP01:26

Endoscopic Procedures V: ERCP

Endoscopic Retrograde Cholangiopancreatography (ERCP) is a diagnostic procedure that combines endoscopy and fluoroscopy to diagnose and treat conditions related to the bile ducts, pancreatic ducts, and gallbladder. This procedure is beneficial for identifying and addressing blockages, gallstones, strictures, and tumors within the biliary or pancreatic systems. ERCP is both diagnostic and therapeutic, offering the ability to visualize and treat identified problems in one session.
Patient...
4.4K
Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption01:23

Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption

Understanding the physiological differences in the pediatric population is crucial for effective pharmacotherapy. Neonates, infants, and children exhibit significant variations in gastric pH, gastric emptying time, intestinal transit time, and biliary function. These variations profoundly affect oral drug absorption, necessitating a nuanced approach to pediatric dosing.Neonates present with a unique physiological profile, having a gastric pH greater than 4 and faster and more irregular gastric...
377
Pharmacokinetics in Pediatric Patients: Drug Metabolism01:24

Pharmacokinetics in Pediatric Patients: Drug Metabolism

In pediatric care, understanding the nuances of hepatic drug metabolism is crucial, as it significantly differs from that of adults. This divergence is primarily due to the developmental stage of drug-metabolizing enzymes, which affects how medications are processed in the body. In neonates, for instance, the activity of Phase I enzymes—critical for the initial breakdown of drugs—is markedly reduced, functioning at just 20–40% of the levels seen in adults. This reduction poses...
289